MedPath

The effect of CRA Plus Training on treatment model adherence, treatment outcomes and interaction with the working alliance in outpatient addiction care: a RCT

Recruiting
Conditions
Substance use disorders
Registration Number
NL-OMON25251
Lead Sponsor
u funding.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
260
Inclusion Criteria

In order to be eligible to participate in this study, a therapist must meet the following criteria:

· No previous experience with CRA,

· =18 months since start of working at IrisZorg,

· Completed CRA certification within 12 months after completing the CRA basic training,

· Working at an outpatient facility,

· Working with adult patients,

· Written informed consent.

In order to be eligible to participate in this study, a patient must meet the following criteria:

· A primary diagnosis of substance use (meeting the DSM-5 criteria),

· Age 18+,

· Sufficient Dutch language proficiency,

· Written informed consent.

Exclusion Criteria

For therapist subjects there are no additional exclusion criteria. Patients who suffer from severe, current (since intake) psychiatric symptoms (especially manic, psychotic, suicidal and aggressive symptoms) that may endanger themselves or others and jeopardize study adherence will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main study parameter is CRA treatment adherence in terms of the mean number of individual CRA procedures completed by therapists in sessions with each individual patient (range 0-12). Adherence is measured by therapists self-reported adherence per session. The CRA Session Report is used for measuring CRA treatment adherence. Therapists report their use of CRA procedures every session. The treatment trajectories will differ in length. Measurements are made up to a maximum of one year.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath